Twist Bioscience and MedGenome have partnered to address the growing challenges of rare diseases in India by leveraging advanced genetic research and biotechnology. The collaboration focuses on applying cutting-edge genomic technologies to improve the diagnosis, treatment, and management of rare diseases, which often go undiagnosed or misdiagnosed in the country.

India, with its large and diverse population, faces unique healthcare challenges, particularly in the field of rare diseases. These conditions often lack awareness, adequate diagnostic tools, and treatment options. With MedGenome’s expertise in genomics and Twist Bioscience’s advanced DNA synthesis capabilities, the partnership aims to develop more effective diagnostic solutions and provide better access to personalized treatments.

This collaboration will involve using genetic testing to identify rare genetic mutations and create tailored therapies for patients. By incorporating next-generation sequencing and other molecular techniques, they hope to improve early detection, enhance personalized medicine approaches, and create a broader genetic database specific to the Indian population. This will enable more accurate diagnosis and better-targeted therapies for rare diseases, ultimately improving patient outcomes and quality of life.

The partnership represents a significant step toward transforming healthcare in India by addressing the unmet need for rare disease management and improving the accessibility of advanced genetic tools for diagnosis and treatment.

4o mini